Off to the Races: The FAA Initiates Informal Drone Rulemaking
Client Alert | 1 min read | 02.14.19
Yesterday, the Federal Aviation Administration (FAA) posted in the Federal Register the Notice of Proposed Rulemaking for Operations of Small Unmanned Aircraft Systems over People and the Advanced Notice of Proposed Rulemaking for Safe and Secure Operations of Small Unmanned Aircraft Systems. The substance and implications of the draft rules were explored in previous client alerts and can be accessed here and here. Comments to both notices are due April 15, 2019.
The FAA also issued an interim final rule requiring small drone owners to display their FAA-issued registration number on the exterior of the aircraft. This is a change from the current rule, which only requires that the number be readily accessible and readable at a close distance. Under the new rule, owners will no longer have the flexibility to place the number in an enclosed compartment on the device, a practice which “presents an imminent risk of harm to first responders,” according to the rule. The rule is effective February 25, 2019, without the usual notice and comment period. This immediate implementation further underscores the Government’s concern over the unique security risks posed by small drones. Interested parties should submit comments by March 15, 2019, as the rule may be amended based on comments received.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief



